Macroencapsulation protects against sensitization after allogeneic islet transplantation in rats

Transplantation

Volumn 82, Issue 3, 2006, Pages 393-397

  Sörenby, Anne K ^a,c   Wu, Guosheng S ^a,b   Zhu, Shunsheng ^a   Wernerson, Annika M ^a   Sumitran Holgersson, Suchitra ^a   Tibell, Annika B H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Immunoprotection; Islet transplantation; Macroencapsulation; Sensitization

Indexed keywords

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; ARTIFICIAL MEMBRANE; BILAMINAR MEMBRANE; CONTROLLED STUDY; ENCAPSULATION; EVALUATION; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT REJECTION; GRAFT SURVIVAL; HEART CONTRACTION; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HISTOLOGY; MACROENCAPSULATION; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SENSITIZATION; SURVIVAL TIME;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; ISLETS OF LANGERHANS TRANSPLANTATION; POLYTETRAFLUOROETHYLENE; RATS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747147781     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000228912.62374.44     Document Type: Article

References (24)

1. Scharp DW, Mason NS, Sparks RE. Islet immuno-isolation: the use of hybrid artificial organs to prevent islet tissue rejection. World J Surg 1984; 8(2): 221.
2. Scharp DW, Swanson CJ, Olack BJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects. Diabetes 1994; 43(9): 1167.
3. Geller RL, Loudovaris T, Neuenfeldt S, et al. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Ann N Y Acad Sci 1997; 831: 438.
4. Keown PA. The highly sensitized patient: etiology, impact, and management. Transplant Proc 1987; 19(1 Pt 1): 74.
5. Brauker J, Martinson LA, Young SK, Johnson RC. Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. Transplantation 1996; 61(12): 1671.
6. Gill RG. Antigen presentation pathways for immunity to islet transplants. Relevance to immunoisolation. Ann N Y Acad Sci 1999; 875: 255.
7. Gill RG. Use of small animal models for screening immunoisolation approaches to cellular transplantation. Ann N Y Acad Sci 2001; 944: 35.
8. Gray DW. Encapsulated islet cells: the role of direct and indirect presentation and the relevance to xenotransplantation and autoimmune recurrence. Br Med Bull 1997; 53(4): 777.
9. Gray DW. An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Ann N Y Acad Sci 2001; 944: 226.
10. Loudovaris T, Mandel TE, Charlton B. CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. Transplantation 1996; 61(12): 1678.
11. Brauker JH, Carr-Brendel VE, Martinson LA, et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res 1995; 29(12): 1517.
12. Padera RF, Colton CK. Time course of membrane microarchitecture-driven neovascularization. Biomaterials 1996; 17(3): 277.
13. Sutton R, Peters M, McShane P, et al. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 1986; 42(6): 689.
14. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57(2): 225.
15. Xu B, Broome U, Uzunel M, et al. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am J Pathol 2003; 163(4): 1275.
16. Rose AG, Cooper DK, Human PA, Reichenspurner H, Reichart B. Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J Heart Lung Transplant 1991; 10(2): 223.
17. Rose AG, Cooper DK. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 1996; 15(8): 804.
18. Forbes RD, Kuramochi T, Guttmann RD, et al. A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat. Lab Invest 1975; 33(3): 280.
19. Tibell A, Rafael E, Wennberg L, et al. Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant 2001; 10(7): 591.
20. Orlowski T, Godlewska E, Moscicka M, Sitarek E. The influence of intraperitoneal transplantation of free and encapsulated Langerhans islets on the second set phenomenon. Artif Organs 2003; 27(12): 1062.
21. Lanza RP, Beyer AM, Chick WL. Xenogenic humoral responses to islets transplanted in biohybrid diffusion chambers. Transplantation 1994; 57(9): 1371.
22. Kulseng B, Skjak-Braek G, Ryan L, et al. Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 1999; 67(7): 978.
23. Shiroki R, Mohanakumar T, Scharp DW. Analysis of the serological and cellular sensitization induced by encapsulated human islets transplantation in type I and type II diabetes patients. Cell Transplant 1995; 4(5): 535.
24. Siebers U, Zekorn T, Horcher A, et al. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients. Transplant Proc 1994; 26(2): 787.